This class of drugs has dramatically changed diabetes care
Messiah notes that clinicians have more effective medical therapies than ever before, but scientists still know remarkably little about the optimal sequencing of medications and MBS, or which patients benefit most from each approach
The mechanism is well-characterized at the biochemical level: GSH inhibits tyrosinase, the rate-limiting enzyme in melanin biosynthesis, by binding to its copper-containing active site
The first is semaglutide: Ozempic is the lower-dose version approved for type 2 diabetes, and Wegovy is the higher-dose version approved for obesity
Stress Management: High stress can lead to emotional eating and hormonal imbalances
Muscle Loss and Postural Changes During GLP-1 Therapy GLP-1 medications reduce appetite and caloric intake, but they don't distinguish between fat and lean muscle